Mucoratio (Acetylcysteine)

Acetylcysteine acts as a mucolytic agent to thin and loosen mucus in various respiratory conditions.

• Chronic obstructive pulmonary disease (COPD): helps loosen thick bronchial secretions, facilitating expectoration and improving airflow.
• Cystic fibrosis: reduces the viscosity of pulmonary mucus, aiding clearance and decreasing infection risk.
• Acute bronchitis: thins airway secretions, supporting cough effectiveness and patient comfort.

• Acetylcysteine cleaves disulfide bonds within mucin glycoproteins, breaking the polymeric network that gives mucus its gel-like consistency. By disrupting these bonds, the drug lowers mucus viscosity and elasticity, making it easier to transport by ciliary action and cough. Additionally, acetylcysteine serves as a precursor for intracellular glutathione, helping to restore antioxidant capacity in airway epithelial cells and contributes to mucosal protection.

Acetylcysteine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Nausea: mild stomach upset often occurring after oral intake.
• Vomiting: occasional expulsion of stomach contents.
• Bad taste or odor: a characteristic sulfur-like sensation in the mouth.
• Abdominal discomfort: cramping or mild pain in the stomach area.
• Headache: transient head pain without other neurological signs.
• Skin rash: mild erythema or itching at the site of contact.

Serious or Rare Side Effects

• Bronchospasm: sudden narrowing of the airways that may cause wheezing.
• Anaphylaxis: severe allergic reaction with hives, swelling, and possible shock.
• Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic dysfunction: elevated liver enzymes indicating liver stress.
• Hemolysis in G6PD deficiency: rapid breakdown of red blood cells.

When prescribing or dispensing Mucoratio, consider the following safety measures.

• Assess renal function: dose may need adjustment in patients with severe kidney impairment.
• Monitor for bronchospasm: discontinue if wheezing or respiratory distress develops.
• Avoid in known hypersensitivity: do not use in individuals with previous allergic reactions to acetylcysteine.
• Use cautiously in asthma: the drug can provoke bronchial irritation in susceptible patients.
• Pregnant or breastfeeding women: evaluate risk‑benefit ratio before use.
• Store at ambient temperature below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Acetylcysteine can affect the activity of several medicines; interactions are classified by clinical significance.

Major Interactions (Avoid)

• Nitroglycerin: concurrent use may cause profound hypotension and syncope.
• Activated charcoal: reduces acetylcysteine absorption when taken together.

Moderate Interactions (Monitor Closely)

• Warfarin: acetylcysteine may enhance anticoagulant effect, requiring INR monitoring.
• Antihistamines: may increase sedation or drowsiness when combined.
• Carbamazepine: possible alteration of drug metabolism, necessitating therapeutic level checks.